Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

U.S. patent issued to NitroMed, providing protection for MED/FSAD treatment program

April 28, 1999

Medtronic's urinary control device approved by FDA

April 28, 1999

Urethra-selective alpha1-agonists under development at Mitsui for urinary incontinence

April 27, 1999

News from FASEB: YM-905 is a bladder-specific M3 receptor antagonist

April 20, 1999

New compound for BPH in active preclinical development at Merck & Co. and Synaptic

April 20, 1999

New frontiers in gene therapy: treatment of erectile dysfunction

April 20, 1999

(+)-SNAP-6991 discovered at Synaptic and Merck as orally active, uroselective alpha1a blocker

April 5, 1999

New antimuscarinic piperidine derivative from Taisho inhibits bladder contractions

April 1, 1999

Pharmacokinetics and pharmacodynamics of VPA-985 in healthy volunteers

March 31, 1999

Aminoethylphenoxyacetic acids for urinary lithiasis in development at Kissei

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...